Brenus Pharma publishes promising proof of concept results of their therapeutic platform in the scientific Frontiers in Oncology journal
BIG BPI – Brenus Pharma took part in the roundtable “Biotherapies: What potential for technology platforms?”
BIO SPACE – Brenus Pharma Raises $25 Million to Accelerate Clinical Trials of Its Precision Anti-cancer immunotherapy
THE TIMES MAGAZINE – Brenus Pharma secures $25 million to propel clinical trials for precision anticancer immuotherapy
Brenus Pharma raises $25 million to accelerate clinical trials of its precision anticancer immunotherapy
Brenus Pharma graduates from the Creative Destruction Lab’s 2023/2024 global cancer stream, in partnership with north American universities
